✦ LIBER ✦

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study

✍ Scribed by Kibel, A.S.

Book ID: 123341359
Publisher: Elsevier Science
Year: 2011
Weight: 46 KB
Volume: 2011
Category: Article
ISSN: 0084-4071
DOI: 10.1016/j.yuro.2011.06.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Denosumab versus zoledronic acid for tre

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

✍ Karim Fizazi; Michael Carducci; Matthew Smith; Ronaldo Damião; Janet Brown; Lawr 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 840 KB

Re: Denosumab Versus Zoledronic Acid for

Re: Denosumab Versus Zoledronic Acid for Treatment of Bone Metastases in Men With Castration-Resistant Prostate Cancer: A Randomised, Double-Blind Study

✍ Walsh, Patrick C. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 110 KB

Denosumab versus zoledronic acid in pati

Denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer: Results from a phase 3 randomized trial

✍ J. Brown*; M. Carducci; K. Fizazi; M. Smith; R. Damião; L. Karsh; P. Milecki; H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

176 NUMBER NEEDED TO TREAT AND RISK BENE

176 NUMBER NEEDED TO TREAT AND RISK BENEFIT ANALYSIS OF DENOSUMAB VERSUS ZOLEDRONIC ACID IN THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER PATIENTS WITH BONE METASTASES

✍ Xie, Jipan; Diener, Melissa; Wu, Eric; Sorg, Rachael; Yu, Andrew; Namjoshi, Madh 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

20LBA A double-blind, randomized study o

20LBA A double-blind, randomized study of denosumab versus zoledronic acid for the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma

✍ D. Henry; R. von Moos; S. Vadhan-Raj; V. Hungria; A. Spencer; V. Hirsh; J. Wang; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

C176 PROLONGED BONE METASTASIS-FREE SURV

C176 PROLONGED BONE METASTASIS-FREE SURVIVAL IN MEN WITH CASTRATE-RESISTANT PROSTATE CANCER RECEIVING DENOSUMAB: RESULTS FROM A PHASE 3, RANDOMISED, DOUBLE-BLIND TRIAL

✍ T. Borkowski; M. Smith; F. Saad; R. Coleman; N. Shore; K. Fizazi; B. Tombal; K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 306 KB